Previous Article | Next Article 
Journal of Clinical Microbiology, November 2004, p. 5364-5367, Vol. 42, No. 11
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.11.5364-5367.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Polymorphisms of the Fimbria fim3 Gene of Bordetella pertussis Strains Isolated in Canada
Raymond S. W. Tsang,1*
Allan K. H. Lau,1
Michelle L. Sill,1
Scott A. Halperin,2
Paul Van Caeseele,3
Frances Jamieson,4 and
Irene E. Martin1
Vaccine Preventable Bacterial Diseases Division, National Microbiology Laboratory, Population and Public Health Branch, Health Canada,1
Cadham Provincal Laboratory, Manitoba Health, Winnipeg, Manitoba,3
Department of Microbiology, Immunology and Pediatric Infectious Diseases, Dalhousie University, Halifax, Nova Scotia,2
Ontario Public Health Laboratory, Ministry of Health and Long Term Care, Toronto, Ontario, Canada4
Received 19 January 2004/
Returned for modification 29 February 2004/
Accepted 23 June 2004
The fim genes which code for the fimbria protective antigens present in both the inactivated whole-cell and acellular vaccines were analyzed in 86 Canadian Bordetella pertussis isolates. At least one of the novel mutations identified was found to involve a surface epitope that has been mapped by serum antibodies from infected or vaccinated subjects.
* Corresponding author. Mailing address: National Microbiology Laboratory, 1015 Arlington St., Winnipeg, Manitoba, Canada R3E 3R2. Phone: (204) 789-6020. Fax: (204) 789-2018. E-mail:
rtsang{at}hc-sc.gc.ca.
Journal of Clinical Microbiology, November 2004, p. 5364-5367, Vol. 42, No. 11
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.11.5364-5367.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Litt, D. J., Neal, S. E., Fry, N. K.
(2009). Changes in Genetic Diversity of the Bordetella pertussis Population in the United Kingdom between 1920 and 2006 Reflect Vaccination Coverage and Emergence of a Single Dominant Clonal Type. J. Clin. Microbiol.
47: 680-688
[Abstract]
[Full Text]
-
Stenger, R. M., Poelen, M. C. M., Moret, E. E., Kuipers, B., Bruijns, S. C. M., Hoogerhout, P., Hijnen, M., King, A. J., Mooi, F. R., Boog, C. J. P., van Els, C. A. C. M.
(2009). Immunodominance in Mouse and Human CD4+ T-Cell Responses Specific for the Bordetella pertussis Virulence Factor P.69 Pertactin. Infect. Immun.
77: 896-903
[Abstract]
[Full Text]
-
Hallander, H., Advani, A., Riffelmann, M., von Konig, C. H. W., Caro, V., Guiso, N., Mooi, F. R., Gzyl, A., Kaltoft, M. S., Fry, N. K., Mertsola, J., He, Q.
(2007). Bordetella pertussis Strains Circulating in Europe in 1999 to 2004 as Determined by Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol.
45: 3257-3262
[Abstract]
[Full Text]
-
Borisova, O., Kombarova, S. Y., Zakharova, N. S., van Gent, M., Aleshkin, V. A., Mazurova, I., Mooi, F. R.
(2007). Antigenic Divergence between Bordetella pertussis Clinical Isolates from Moscow, Russia, and Vaccine Strains. CVI
14: 234-238
[Abstract]
[Full Text]
-
Register, K. B., Yersin, A. G.
(2005). Analytical Verification of a PCR Assay for Identification of Bordetella avium. J. Clin. Microbiol.
43: 5567-5573
[Abstract]
[Full Text]